Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.

被引：0
|
作者：
Lowry, Kathryn P.
Geuzinge, H. Amarens
Stout, Natasha K.
Alagoz, Oguzhan
Hampton, John M.
Kerlikowske, Karla
Miglioretti, Diana L.
Schecter, Clyde
Sprague, Brian L.
Trentham-Dietz, Amy
Tosteson, Anna N. A.
Van Ravesteyn, Nicolien
Yaffe, Martin
Yeh, Jennifer
Couch, Fergus
Kraft, Peter
Polley, Eric
Mandelblatt, Jeanne S.
Kurian, Allison W.
Robson, Mark E.
机构：
[1] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Univ Wisconsin, Madison, WI USA
[6] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Univ Calif Davis, Sch Med, Davis, CA USA
[9] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[10] Univ Vermont, Burlington, VT USA
[11] Geisel Sch Med, Lebanon, NH USA
[12] Boston Childrens Hosp, Boston, MA USA
[13] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[14] Mayo Clin, Harvard Sch Publ Hlth, Rochester, MN USA
[15] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[16] Stanford Sch Med, Stanford, CA 94305 USA
[17] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10500
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Moss, Charlotte L.
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1162 - 1168
  • [42] Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort (vol 121, pg 203, 2010)
    McInerney, N. M.
    Miller, N.
    Rowan, A.
    Colleran, G.
    Barclay, E.
    Curran, C.
    Kerin, M. J.
    Tomlinson, I. P.
    Sawyer, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 729 - 729
  • [43] Breast cancer in Slovene CHEK2 mutation carriers
    Blatnik, A.
    Strojnik, K.
    Stegel, V.
    Drago, V. Etrajcic
    Klancar, G.
    Novakovic, S.
    Krajc, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 412 - 412
  • [44] 21-gene recurrence score results according to germline pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 and Lynch Syndrome genes
    Kurian, Allison W.
    Abrahamse, Paul
    Ward, Kevin
    Hamilton, Ann S.
    Deapen, Dennis
    Shak, Steven
    Katz, Steven J.
    CANCER RESEARCH, 2020, 80 (04)
  • [45] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Haeyoung Kim
    Dae-Yeon Cho
    Doo Ho Choi
    Mijin Oh
    Inkyung Shin
    Won Park
    Seung Jae Huh
    Seok Jin Nam
    Jeong Eon Lee
    Seok Won Kim
    Breast Cancer Research and Treatment, 2017, 161 : 95 - 102
  • [46] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Kim, Haeyoung
    Cho, Dae-Yeon
    Choi, Doo Ho
    Oh, Mijin
    Shin, Inkyung
    Park, Won
    Huh, Seung Jae
    Nam, Seok Jin
    Lee, Jeong Eon
    Kim, Seok Won
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 95 - 102
  • [47] Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia
    Mesaric, Vita Andreja
    Blatnik, Ana
    Staric, Kristina Drusany
    Strojnik, Ksenija
    Stegel, Vida
    Hotujec, Simona
    Dragos, Vita Setrajcic
    Skerl, Petra
    Novakovic, Srdjan
    Krajc, Mateja
    HUMAN GENOMICS, 2024, 18 (01)
  • [48] Toward a better understanding of the experience of patients with moderate penetrance breast cancer gene pathogenic/likely pathogenic variants: A focus on ATM and CHEK2
    McCormick, Shelley
    Hicks, Stephanie
    Wooters, Mackenzie
    Grant, Carly
    JOURNAL OF GENETIC COUNSELING, 2022, 31 (04) : 956 - 964
  • [49] Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
    Graham B Byrnes
    Melissa C Southey
    John L Hopper
    Breast Cancer Research, 10
  • [50] Analysis of germ-line mutations in non-syndromic malignancies with concurrent pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2, and RAD51C/D
    Miller, E. M.
    Mullins, J.
    Jain, A.
    Chaudhry, A.
    Mi, D.
    Usman, R.
    Jones, T.
    Baca, Y.
    Xiu, J.
    Korn, W. M.
    Cummings, S.
    Vidal, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1229 - S1229
12345